Medical AI

Trialbee's new AI agent gives patients unprecedented choice in screening, aiming to slash wait times and fix a critical bottleneck in medical research.

A new partnership will use AI to decode 200,000 patient records, turning once-inaccessible clinical notes into a powerful weapon against retinal disease.

Beyond predicting structures, MoleculeMind's QuantaMind simulates entire chemical reactions, offering a dynamic view that could slash R&D costs in pharma.

With $14M from Khosla Ventures, AI startup Nara Health challenges the status quo with alternative plans, promising radical cost savings for employers.

Milliman MedInsight is embedding AI directly into analytics workflows, but its strategy isn't about chasing buzzwords. It's a calculated move to build trust.

New research shows a contactless device can predict worsening asthma by listening for coughs, heralding a new era of proactive, data-driven healthcare.

A landmark partnership is digitizing millions of tissue samples across Europe, centralizing expertise and paving the way for AI-driven precision medicine.

Glucotrack secures $11.5M to fund a breakthrough diabetes monitor, but a look beneath the surface reveals a high-stakes gamble on AI and shareholder value.

Beyond the chatbot, a $12B market for AI medical assistants is rewiring healthcare, promising to ease burnout and empower patients. But can we trust the code?

ARPA-H taps UpDoc, Microsoft, and OpenAI to build an autonomous AI clinician for heart disease, a high-stakes bet on the future of medicine.

A new report reveals a silent crisis in healthcare: nearly half of organizations say document delays harm patients, creating an "action gap" that costs billions.

The firm’s upcoming Town Hall reveals more than strong Q2 growth; it showcases a deliberate strategy to dominate the future of equitable, AI-assisted care.

Miami's DermaSensor lands $5M and four major US partnerships, setting the stage to rapidly scale its FDA-cleared AI skin cancer detection device nationwide.

A high schooler's award-winning AI model to simulate cancer cells is more than a project; it's a blueprint for a faster, cheaper, and more humane future.

New AI-powered analysis of Endeavor BioMedicines' taladegib shows significant lung volume gains, offering a glimmer of hope for reversing damage in IPF.

RXNT, a Maryland firm, just topped a list of 162 practice management vendors. We explore how its integrated system is winning over smaller medical practices.

Pearl’s new FDA-cleared 3D imaging AI is set to democratize advanced diagnostics, empowering general dentists to see more and reshaping patient care.

A new report reveals Indonesia's stroke crisis isn't just medical—it's logistical. Delays in referrals and insurance are the real killers. Can tech and system reform fix it?

A new deal between Owkin and Boehringer Ingelheim isn't just a partnership; it's a look at the future where AI scientists and deep data drive innovation.

A landmark decision by Medicare provides reimbursement for Bayesian Health's AI sepsis tool, accelerating the fight against a leading cause of hospital deaths.